Fig. 4From: Health professionals’ preferences with the use of pegfilgrastim on-body injector at oncology centers in 8 cities in ColombiaResults for point-allocation exercise between different reasons for choosing a particular Pegfilgrastim administration option The most frequent reason to be considered when choosing a Pegfligrastim administration method is preventing the patient from returning to the center after chemotherapy administration for all hypothetical casesBack to article page